Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel

BACKGROUND: Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder with no disease modifying therapy currently available. Data on the costs associated with PSP are scarce. This study aims to assess the direct medical expenditure of patients with PSP (PwPSP) thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Barer, Yael, Cohen, Raanan, Grabarnik-John, Meital, Ye, Xiaolan, Zamudio, Jorge, Gurevich, Tanya, Chodick, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345081/
https://www.ncbi.nlm.nih.gov/pubmed/37069439
http://dx.doi.org/10.1007/s00415-023-11714-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345081/
https://www.ncbi.nlm.nih.gov/pubmed/37069439
http://dx.doi.org/10.1007/s00415-023-11714-1

Ejemplares similares